When was Xbiome founded?

Xbiome was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Xbiome located?

Xbiome is headquartered in Shenzhen, China.

How many employees does Xbiome have?

As of Feb 28, 2026, the latest employee count at Xbiome is 51.

Is Xbiome a funded company?

Xbiome is a funded company, having raised a total of $108M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 2018.

When was the latest funding round of Xbiome?

Xbiome's latest funding was a $***** Series B round on Dec 22, 2021, with participation from 7 investors. Its primary sector is Life Sciences Tech. In China, the Life Sciences Tech sector has seen $89M in funding in 2026 to date.

Where does Xbiome rank among its competitors?

Xbiome ranks 64th amongst 554 active competitors, of which 141 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Evotec, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of Xbiome?

Xbiome's top competitors include Evotec, Benchling and Helix. Among them, Evotec secured the most recent funding round in January, 2026.

Xbiome - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of an AI-enabled bioinformatics platform for the discovery of drugs using intestinal microbiome. The company uses Fecal microbiota transplantation (FMT) technology for the development of drugs for multiple diseases. It includes extraction of microbiota from the stool of healthy people through various methods and then transplant it into patients and used to treat various diseases.

Website: xbiome.com
Email ID: *****@xbiome.com
Phone Number: +86 **********

Key Metrics

Founded Year

2017

Location

Shenzhen, China

Stage

Series B

Total Funding

$108M in 5 rounds

Latest Funding Round

Series B, Dec 22, 2021, $*****

Investors

Gaorong Capital & 10 more

Ranked

64^th among 554 active competitors

Employee Count

51 as on Feb 28, 2026

Similar Companies

Innovaccer & 3017 more

View Xbiome's full profile

Xbiome has raised a total funding of $108M over 5 rounds. Its first funding round was on Aug 2018. Its latest funding round was a Series B round on Dec 22, 2021 for $*****. 7 investors participated in its latest round. Xbiome has 10 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Xbiome:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 22, 2021	9638399	Series B	4968658	6982872	4111391	7660667
Dec 01, 2020	1514032	Series B	1393059	5724475	7990921	Legend Capital & 1 more
Nov 02, 2019	1563163	Series B	1413800	6912171	Legend Capital	Gaorong Capital & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Xbiome's funding rounds and investors

Xbiome's employee count trend

Xbiome has 51 employees as of Feb 26. Here is Xbiome's employee count trend over the years:

Uncover Xbiome's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Xbiome include Evotec, Benchling and Helix. Here is the list of Top 10 competitors of Xbiome, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Evotec 1993, Hamburg (Germany), Public	Provider of drug discovery alliance and development services for biopharma sector	$25M	TVM Capital Life Science, Mubadala & 21 others	76/100
2nd	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 28 others	73/100
3rd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	Kleiner Perkins, DFJ Growth & 12 others	71/100
4th	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	70/100
5th	Insitro 2018, San Francisco (United States), Series C	Developer of machine learning platform for drug discovery and development	$643M	Andreessen Horowitz, Foresite Capital & 18 others	70/100
6th	Cytel 1987, Cambridge (United States), Acquired	Provider of data analysis and statistical solutions for the life sciences industry	$2M	Autonomy Ventures, Merck & 3 others	67/100
7th	Immunai Technologies 2018, United States, Series B	Developer of next-generation of immunomodulatory therapeutics	$295M	Viola Group, TLV Partners & 14 others	66/100
8th	Engine Biosciences 2014, Singapore (Singapore), Series A	Developer of platform technology for combinatorial genetics discovery	$86M	Polaris Partners, DHVC & 18 others	66/100
9th	Metagenomi 2016, Berkeley (United States), Public	Digital gene editing technologies for drug development	$376M	Humboldt Fund, RA Capital Management & 22 others	65/100
10th	Asimov 2017, Boston (United States), Series B	Provider of integrated suite for advanced genetic design and manufacturing	$237M	Andreessen Horowitz, CPP Investments & 11 others	65/100
64th	Xbiome 2017, Shenzhen (China), Series B	Developer of an AI-enabled bioinformatics platform for the discovery of drugs using intestinal microbiome	$108M	Primavera, Gaorong Capital & 9 others	45/100